NCT04677205View on ClinicalTrials.gov

Molecular Signature From Tumor to Lymph Nodes

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

March 30, 2021

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2027

Conditions
Lung CancerStage IIIA-cN2Operated With Curative IntentPrimary Tumor Tissue AvailableNode Tumor Tissue Available
Trial Locations (12)

75015

ACTIVE_NOT_RECRUITING

Hegp-Aphp, Paris

RECRUITING

Hôpital Européen Georges-Pompidou, Paris

Unknown

NOT_YET_RECRUITING

Hôpital du Haut-Lévêque, CHU de Bordeaux, Bordeaux

NOT_YET_RECRUITING

Hôpital Militaire Percy, Clamart

NOT_YET_RECRUITING

Hôpital Nord, Marseille

NOT_YET_RECRUITING

Hôpital Pasteur, CHU de Nice, Nice

NOT_YET_RECRUITING

Hôpital Bichat, Paris

NOT_YET_RECRUITING

Hôpital Cochin, Paris

NOT_YET_RECRUITING

Hôpital Pontchaillou, CHU de Rennes, Rennes

NOT_YET_RECRUITING

Hôpitaux universitaires de Strasbourg, Strasbourg

NOT_YET_RECRUITING

Hôpital Larrey, CHU de Toulouse, Toulouse

NOT_YET_RECRUITING

CHRU de Tours, Tours

All Listed Sponsors
collaborator

National Cancer Institute, France

OTHER_GOV

collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Université de Paris

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER